Role of B-type natriuretic peptide as a marker of mortality in acute kidney injury patients treated with continuous renal replacement therapy

Renal Failure

Volumn 35, Issue 9, 2013, Pages 1216-1222

  Jeong, Eu Gene ^a   Nam, Hwa Seong ^a   Lee, Su Mi ^a   An, Won Suk ^a   Kim, Seong Eun ^a   Son, Young Ki ^a  

^a Dong A University College of Medicine   (South Korea)

Author keywords

Acute kidney injury; B type natriuretic peptide; Mortality; Renal replacement therapy; Volume overload

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; DIURETIC AGENT; NAFAMSTAT MESILATE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; CONTINUOUS RENAL REPLACEMENT THERAPY; FEMALE; HUMAN; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; TREATMENT OUTCOME;

ACUTE KIDNEY INJURY; AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; RENAL REPLACEMENT THERAPY; REPUBLIC OF KOREA;

EID: 84884258320     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2013.823870     Document Type: Article

References (39)

1. Ahlstrom A, Tallgren M, Peltonens S, Rasanen P, Pettila V. Survival and quality of life of patients requiring acute renal replacement therapy. Intensive Care Med. 2005;31(9):1222-1228
2. Bagshaw SM, Laupland KB, Doig CJ, et al. Prognosis for long-Term survival and renal recovery in critically ill patients with severe acute renal failure: A population-based study. Crit Care. 2005; 9(6):R700-R709
3. Korkeila M, Ruokonen E, Takala J. Costs of care, long-Term prognosis and quality of life in patients requiring renal replacement therapy during intensive care. Intensive Care Med. 2000; 26(12):1824-1831
4. Uchinos S. The epidemiology of acute renal failure in the world. Curr Opin Crit Care. 2006;12(6):538-543
5. Bellomo R, Mehta R. Acute renal replacement in the intensive care unit: Now and tomorrow. New Horiz. 1995;3(4):760-767
6. Canaud B, Mion C. Extracorporeal treatment of acute renal failure: Methods, indications, quantified and personalized therapeutic approach. Adv Nephrol Necker Hosp. 1995;24:271-313
7. Barton IK, Hilton PJ, Taub NA, et al. Acute renal failure treated by hemofiltration: Factors affecting outcome. Q J Med. 1993; 86(2):81-90
8. Sasaki S, Gando S, Kobayashi S, et al. Predictors of mortality in patients treated with continuous hemofiltration for acute renal failure in an intensive care setting. ASAIO. 2001;47(1):86-91
9. de Denus S, Pharand C, Williamson DR. Brain natriuretic peptide in the management of heart failure: The versatile neurohormone. Chest. 2004;125(2):652-668
10. Azzazy HM, Christenson RH. B-Type natriuretic peptide: Physiologic role and assay characteristics. Heart Fail Rev. 2003; 8(4):315-320
11. Januzzi Jr. JL, Camargo CA, Anwaruddin S, et al. The N-Terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol. 2005;95(8):948-954
12. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-Type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347(3):161-167
13. Rudiger A, Gasser S, Fischler MN, Hornemann T, von Eckardstein A, Maggiorini M. Comparable increase of B-Type natriuretic peptide and amino-Terminal pro-B-Type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit Care Med. 2006;34(8):2140-2144
14. Rana R, Vlahakis NE, Daniels CE Rana R, Vlahakis NE, Daniels C. B-Type natriuretic peptide in the assessment of acute lung injury and cardiogenic pulmonary edema. Crit Care Med. 2006; 34(7):1941-1946
15. Lega JC, Lacasse Y, Lakhal L, Provencher S. Natriuretic peptides and troponins in pulmonary embolisms: A meta-Analysis. Thorax. 2009;64(10):869-875
16. James ML, Blessing R, Phillips-Bute BG, Bennett E, Laskowitz DT. S100B and brain natriuretic peptide predict functional neurological outcome after intracerebral hemorrhage. Biomarkers. 2009;14(6):388-394
17. Rivers EP, McCord J, Otero R, Jacobsen G, Loomba M. Clinical utility of B-Type natriuretic peptide in early severe sepsis and septic shock. J Intensive Care Med. 2007;22(6):363-373
18. Hoffmann U, Brueckmann M, Bertsch T, et al. Increased plasma levels of NT-proANP and NT-proBNP as markers of cardiac dysfunction in septic patients. Clin Lab. 2005;51(7-8):373-379
19. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: The second international cocsensus conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):204-212
20. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. Prognosis in acute organ system failure. Ann Surg. 1985;202(6):685-693
21. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ ACCP/ATS/SIS International Sepsis definitions Conference. Crit Care Med. 2003;31(4):1250-1256
22. Prowle JR, Bellomo R. Continuous renal replacement therapy: Recent advancement and future research. Nat Rev Nephrol. 2010; 6(9):521-529
23. Schwilk B, Wiedeck H, Stein B, reinelt H, Treber H, Bothner U. Epidemiology of acute renal failure and outcome of hemodiafiltration in intensive care. Intensive Care Med. 1997;23(12):1204-1211
24. Baudouin SV, Wiggins J, Keogh BF, Morgan CJ, Evans TW. Continuous veno-venous hemofiltration following cardio-pulmonary bypass. Indications and outcome in 35 patients. Intensive Care Med. 1993;19(5):290-293
25. Kinnunen P, Vuolteenaho O, Ruskoaho H. Mechanisms of arterial and brain natriuretic peptide release from rat ventricular myocardium: Effect of stretching. Endocrinology. 1993;132(5):1961-1970
26. Tokola H, Hautala N, Marttila M, et al. Mechanical load-induced alterations in B-Type natriuretic peptide gene expression. Can J Physiol Pharmacol. 2001;79(8):646-653
27. Mollamach F, Zoccali C, Tripepi G, et al. Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int. 2001; 59(4):1559-1566
28. Sakr Y, Vincent JL, Reinhart K, et al. Sepsis Occurrence in Acute Ill Patients Investigations. High tidal volume and positive fluid balance are associated with worse outcome in acute lung injury. Chest. 2005;128(5):3098-3108
29. Vincent JL, Sakr Y, Sprung CL, et al. Sepsis Occurrence in Acute Ill patients Investigators. Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med. 2006;34(2):344-353
30. Daniels LB, Allison MA, Clopton P, et al. Use of natriuretic peptides in pre-participation screening of college athletes. Int J Cardiol. 2008;124(3):411-414
31. de Cal M, Haapio M, Cruz DN, et al. B-Type natriuretic peptide in the critically ill with acute kidney injury. Int J Nephrol. 2011; 951629:1-6
32. Fulop T, Pathak MB, Schmidt DW, et al. Volume-Related weight gain and subsequent mortality in acute renal failure patients treated with continuous renal replacement therapy. ASAIO J. 2010; 56(4):333-337
33. McLean AS, Huang SJ, Hyams S, et al. Prognostic value of B-Type natriuretic peptide in severe sepsis and septic shock. Crit Care Med. 2007;35(4):1019-1026
34. Ma KK, Ogawa T, de Bold AJ. Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J Mol Cell Cardiol. 2004;36(4):505-513
35. DeFilippi CR, Fink JC, Nass CM, Cher H, Christenson R. N-Terminal pro-B-Type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis. Am J Kidney Dis. 2005;46:35-44
36. Khan IA, Fink J, Nass C, Chen H, Christenson R, de Filippi CR. N-Terminal pro-B-Type natriuretic peptide and B-Type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients. Am J Cardiol. 2006;97(10):1530-1534
37. Mark PB, Stewart GA, Gansevoort RT, et al. Diagnostic potential of circulating natriuretic peptides in chronic kidney disease. Nephrol Dial Tranplant. 2006;21(2):402-410
38. Takami Y, Horio T, Iwashima Y, et al. Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF. Am J Kidney Dis. 2004;44(3):420-428
39. Cheng V, Kazanagra R, Garcia A, et al. A rapid bedside test for B-Type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: A pilot study. J Am Coll Cardiol. 2001;37(2):386-391